Related Experiment Video
Updated: Aug 29, 2026
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Corneo-conjunctival autograft transplantation for pterygium surgery
Eric Frau1, Marc Labétoulle, Marie Lautier-Frau
1Institute Gustave Roussy, Villejuif, France. eric.frau@bct.ap-hop-paris.fr
Purpose:
To evaluate the efficacy of surgical management of pterygium with corneo-conjunctival autograft transplantation.
Setting:
Ophthalmology Department, Bicêtre Hospital, University Paris XI and the Assistance Publique Hôpitaux de Paris, France.
Methods:
The records of 104 patients (114 eyes), comprising 40 women and 64 men, who underwent corneo-conjunctival autograft transplantation for primary (104 eyes) and recurrent (10 eyes) pterygia between 1992 and 1998, were reviewed in a retrospective survey. Follow-up ranged from 12 to 78 months (mean 22.5 months).
Results:
All grafts were planted promptly and donor sites re-epithelialized with no excessive scar tissue formation. No recurrence was noted. Improvement of visual acuity was achieved in 24 patients and stabilization was achieved in 76 patients. The main complication was progression of corneal astigmatism exceeding 4 dioptres in two patients.
Conclusion:
These results indicate that corneo-conjunctival autograft transplantation is an effective treatment for pterygia.
